Target intelligence / Profile preview

CIRBP antisense RNA 1 (CIRBP-AS1)

Target
CIRBP-AS1
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein coding RNA)
01

Overview

CIRBP antisense RNA 1 (CIRBP-AS1) is a long non-coding RNA transcribed from the antisense strand of the CIRBP gene locus on human chromosome 19. While the protein-coding CIRBP gene acts as a cold-inducible RNA-binding protein involved in the regulation of microRNA processing and angiogenesis, CIRBP-AS1 has been shown to modulate CIRBP expression and to influence the expression of specific microRNAs (such as miR-329-3p and miR-495-3p) that are critical for angiogenesis[1]. Knockdown of CIRBP-AS1 can increase angiogenic potential in endothelial cells, apparently by downregulating CIRBP and altering microRNA expression. CIRBP-AS1 appears to function within epitranscriptomic regulatory networks in cancer and vascular biology, but its precise mechanisms and roles remain incompletely characterized, and it is not considered a direct therapeutic target or receptor[1][5][4][7]. If more detailed transcript sequences, functional experiments, or tissue specificity are needed, these can typically be sourced via Ensembl (ENSG00000267493) or NCBI Gene (ID 148046)[6].

Other names
C19orf23CIRBP antisense gene protein 1CIRBP-AS1 (non-protein coding)Putative uncharacterized protein CIRBP-AS1MGC39338
02

Biological functions

Regulation of gene expressionRegulation of angiogenesis (indirectly via modulation of CIRBP and associated microRNAs)
03

Disease associations

Cancer (emerging evidence as a component in epitranscriptomic regulatory networks in cancer)Other (potentially involved in vascular biology via effects on angiogenesis)

Beyond the preview

Go deeper on CIRBP antisense RNA 1 (CIRBP-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIRBP antisense RNA 1 (CIRBP-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call